APA

Rigg A., Cunningham D., Gore M., Hill M., O'Brien M., Nicolson M., Chang J., Watson M., Norman A., Hill A., Oates J., Moore H. & Ross P. (19970212). A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas. : British journal of cancer.

Chicago

Rigg A, Cunningham D, Gore M, Hill M, O'Brien M, Nicolson M, Chang J, Watson M, Norman A, Hill A, Oates J, Moore H and Ross P. 19970212. A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas. : British journal of cancer.

Harvard

Rigg A., Cunningham D., Gore M., Hill M., O'Brien M., Nicolson M., Chang J., Watson M., Norman A., Hill A., Oates J., Moore H. and Ross P. (19970212). A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas. : British journal of cancer.

MLA

Rigg A, Cunningham D, Gore M, Hill M, O'Brien M, Nicolson M, Chang J, Watson M, Norman A, Hill A, Oates J, Moore H and Ross P. A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas. : British journal of cancer. 19970212.